The current RGBAD market cap is 13.66M. The company's latest EPS is USD 0.3422 and P/E is 5.87.
Year End September 29 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 236k | 237k |
Operating Income | -339k | -686k |
Net Income | 2.44M | 1.16M |
Year End September 29 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 559k | 354k |
Total Liabilities | 8.6M | 5.46M |
Total Equity | -8.04M | -5.1M |
Year End September 29 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Operating | -607k | -174k |
Investing | 25k | N/A |
Financing | -94k | 244k |
Market Cap | 13.66M |
Price to Earnings Ratio | 5.87 |
Price to Sales Ratio | 28.67 |
Price to Cash Ratio | 56.15 |
Price to Book Ratio | -1.33 |
Dividend Yield | - |
Shares Outstanding | 3.38M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 26.49 (88.3%) |
Company Name | Regen Biopharma Inc (PK) |
Address |
50 west liberty street, suite 880 reno, nevada 89501 |
Website | https://www.regenbiopharmainc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.